Two Medtronic Infuse Plaintiffs Obtain $8.45M in Settlements
Two Medtronic Infuse Plaintiffs Will Receive $8.45M. Two individuals who filed lawsuits over Medtronic's controversial Infuse bone graft product will receive a combined total of $8.45 million in settlements. Each of their lawsuits alleged that they were not informed about the risky procedures involving Infuse, which were allegedly … [Read more...] about Two Medtronic Infuse Plaintiffs Obtain $8.45M in Settlements
Medtronic Fights to Have InFuse Injury Claims Preempted by Federal Law
Medtronic InFuse Injury Claims. With numerous lawsuits filed against it over injuries attributed to its InFuse bone growth device, device maker, Medtronic Inc., has been trying to convince various courts nationwide that the federal preemption clause of the federal Food, Drug and Cosmetic Act frees the company from liability for the … [Read more...] about Medtronic Fights to Have InFuse Injury Claims Preempted by Federal Law
Medtronic Infuse Lawsuit Moves Forward as Motion to Remand is Granted
Individuals who are suing Medtronic over the bone graft product InFuse are a step closer to trial. A number of individuals who are suing Medtronic over the bone graft product InFuse are a step closer to trial, as their motion to remand has been granted. The case will be brought from federal court back to the Circuit Court of the City … [Read more...] about Medtronic Infuse Lawsuit Moves Forward as Motion to Remand is Granted
Surgeon Allegedly Performed Unnecessary Infuse Spinal Surgeries
Unnecessary Infuse Spinal Surgeries. A Cincinnati spine surgeon, Dr. Abubakar Atiq Durrani faces federal charges that he persuaded patients to undergo operations they didn’t need. He is accused of billing private and public health care benefit programs for the allegedly fraudulent services.According to reports, Durrani has a … [Read more...] about Surgeon Allegedly Performed Unnecessary Infuse Spinal Surgeries
Medtronic Infuse Clinical Trials Under Fire
Medtronic Infuse Adverse Events. The Side Effect Associated With Medtronic Infuse Bone Graft Product Serious questions were raised about side effects associated with Medtronic Inc.'s Infuse bone graft product by a study published in The Spine Journal last summer. The study found that published reports for 13 Medtronic-fund … [Read more...] about Medtronic Infuse Clinical Trials Under Fire
Medtronic Infuse Worries
Cancer Risks Associated with Medtronic Infuse Bone Growth A study presented this past November raised serious concerns about cancer risks that could be associated with Medtronic Inc.'s Infuse Bone Growth product. The study was conducted by long-time Infuse critic, Dr. Eugene Carragee, and found that within a year of … [Read more...] about Medtronic Infuse Worries
Medtronic Infuse Woes Spawn Shareholder Infuse
Medtronic Infuse Lawsuit Due To Off-Label Use. Medtronic was hit this week with another shareholder lawsuit alleging the company illegally promoted off-label use of its Infuse bone growth product. This lawsuit alleges that because of false statements Medtronic and its officers made regarding Infuse, the company's stock … [Read more...] about Medtronic Infuse Woes Spawn Shareholder Infuse
Medtronic Infuse Controversy
Medtronic Infuse Controversy. With Medtronic Inc's sales of its Infuse bone growth product taking a hit thanks to recent controversies surrounding its possible side effects, several companies could find new markets for their spinal fusion products, according to a report from MedCity News. As we've reported previously, Medtronic is … [Read more...] about Medtronic Infuse Controversy
Dim Future for Medtronic Infuse
Cancer and Other Side Effects of Medtronic Infuse. Medtronic Inc.'s sales of its Infuse (rhBMP-2) product have taken a hit in recent months, thanks to concerns that the bone growth protein may be associated with cancer and other serious side effects. Now one analyst is raising doubts as to whether Medtronic can salvage … [Read more...] about Dim Future for Medtronic Infuse
Medtronic Infuse Shareholder Class Action Lawsuit Certified
Medtronic Infuse Class Action Lawsuit. Medtronic, Inc. got more bad news on the Infuse front yesterday, when a federal judge granted class action status to an investor shareholder lawsuit alleging the company illegally promoted off-label use of the controversial bone growth protein, causing stockholders financial … [Read more...] about Medtronic Infuse Shareholder Class Action Lawsuit Certified
Medtronic Discloses California Infuse Investigation
California Infuse Investigation Underway. Medtronic continues to be plagued by investigations into its controversial Infuse bone growth product. According to its most recent 10-Q filing with the Securities and Exchange Commission (SEC), the California Attorney General issued a subpoena to the company in October seeking … [Read more...] about Medtronic Discloses California Infuse Investigation
Expect Big Fallout from Medtronic Infuse Scandal, Analyst Says
Fallout Could Lead From Medtronic Infuse. The latest furor over Medtronic Inc.'s Infuse bone growth product will likely lead to increased regulatory scrutiny of the spine device, as well as possible class action lawsuits, a Wall Street analyst says. According to a Forbes report, Larry Biegelsen of Wells Fargo says the … [Read more...] about Expect Big Fallout from Medtronic Infuse Scandal, Analyst Says
